Optimal Treatment Protocol for Selective Laser Trabeculoplasty - Repeat Trial

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
Glaucoma is a common eye disease that can lead to blindness. The only known way to reduce the rate of disease progression is by reducing the pressure in the eye (the intraocular pressure, IOP). Selective laser trabeculoplasty (SLT) is an ophthalmic laser intervention with the purpose of reducing the IOP. SLT can be performed in different ways, with four of the treatment protocols being evaluated in the Optimal SLT (OSLT) trial. SLT is a repeatable procedure, but scientific evidence is scarce regarding more than one repetition. In this trial, patients included in the OSLT trial will be invited to the extended trial (OSLT-R), for further follow-up and re-treatment with SLT, if needed.
Epistemonikos ID: 9fbfbb1e1067c4f2c4e139ff2d93ea69d627c9bc
First added on: May 09, 2024